Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
2.020
-0.100 (-4.72%)
At close: Dec 16, 2025, 4:00 PM EST
2.020
0.00 (0.00%)
Pre-market: Dec 17, 2025, 8:44 AM EST

PACB Revenue

In the year 2024, Pacific Biosciences of California had annual revenue of $11.70M, down -2.99%. Pacific Biosciences of California had revenue of $2.82M in the quarter ending December 31, 2024, a decrease of -6.97%.

Revenue (ttm)
$11.70M
Revenue Growth
-2.99%
P/S Ratio
3.86
Revenue / Employee
$268,842
Employees
575
Market Cap
609.85M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202411.70M-361.00K-2.99%
Dec 31, 202312.06M-693.00K-5.43%
Dec 31, 202212.75M970.00K8.23%
Dec 31, 202111.78M617.00K5.53%
Dec 31, 202011.17M1.87M20.09%
Dec 31, 20199.30M3.63M63.97%
Dec 31, 20185.67M1.49M35.74%
Dec 31, 20174.18M3.93M1,597.97%
Dec 31, 2016246.00K99.00K67.35%
Dec 31, 2015147.00K25.00K20.49%
Dec 31, 2014122.00K74.00K154.17%
Dec 31, 201348.00K-188.00K-79.66%
Jul 31, 2012236.00K-885.17K-78.95%
Jul 31, 20111.12M-1.12M-50.07%
Jul 31, 20102.25M975.74K76.84%
Jul 31, 20091.27M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings